Home Blog

Medical cannabis in France: the DGS sets up a working group

After 4 years of discussions around the experimentation of therapeutic cannabis in France, and its launch almost 2 years ago, the General Directorate of Health (DGS) is setting up a working group on the continuation of the experimentation of medical cannabis.

This working group will meet for the first time on December 16, according to information from APMnews.

It provides for “an update on the status of cannabis for medical use within the European Union” as well as discussions, which should have taken place in parallel with the first phase of the experiment, “on the various possible options for an entry into common law in France at the end of experimentation”.

It will bring together experimental stakeholders and external actors involved in one way or another in medical cannabis.

For the former, there will be the Canadian cannabis producer Aurora and its French relay laboratory for experimentation Etypharm, the Canadian Tilray and the French Medipha, the Israeli Panaxia Pharmaceuticals and the French Neuraxpharm, the Australian Little Green Pharma and the French Intsel Chimos, as well as the French Boiron and the Italian Recodarti, the latter two being “only” on the list of replacements and not currently supplying any product.

According to APMnews, more or less external actors will also participate in the experiment, such as:

  • the American Curaleaf which bought Emmac in 2021, Emmac being on the list of replacement suppliers (with Boiron as a distributor)
  • the Jazz Pharmaceuticals and Almirall laboratories, Jazz having acquired GW Pharmaceuticals, producer of Sativex and Epidiolex, in 2021. Almirall is the distributor of these products in Europe. As a reminder, despite a marketing authorization in 2014 for Sativex, it is still not distributed for objectively obscure reasons while Epidiolex is only distributed drop by drop in Temporary Authorization for Use (ATU) nominative

Representatives of Leem (Medicine companies) and Gemme (Generic same medicine) are also invited, as well as members of the National Agency for Safety and Medicines (ANSM), the Social Security Department (DSS) and the Directorate General for Healthcare (DGOS).

Accessories for the maintenance of the shisha


Maintaining a hookah is essential to guarantee its proper functioning, but also your pleasure when using it. Here are the essential accessories to effectively clean your shisha pipe.

Specific accessories and products

The very design of the shisha sometimes makes it difficult to clean. It is for this reason that there are accessories dedicated to cleaning hookahs. They allow you to reach inaccessible corners so that your shisha is perfectly clean.

The accessories and products necessary for the maintenance of a shisha

The bottle brush

Also called a cleaning brush, the brush is essential to keep your shisha in good condition and perfectly clean. It sneaks into the smallest corners and also passes through the narrowest orifices. Its small hairs rub the walls to remove the smallest deposits. Some brush models are fixed and others are flexible to fit the shapes of the most complex hookahs.

The cleaning brush

If the brush is perfect for the vase, the cleaning brush is very useful for the chimney. Thinner, it slips ideally into the duct to rub the walls.

The sponge

The sponge is very useful for cleaning the entire exterior of the shisha, but also for cleaning the hearth. It is a detail not to forget to clean to keep a clean shisha!

Accessories for the maintenance of the shisha

Cotton swabs and cloth

Cotton swabs are ideal for cleaning small parts and pipe mouths for example. As for the cloth, it is used to wipe and remove any traces of water on the vase of the hookah.

The cleaning fluid

You can absolutely use warm soapy water to clean your shisha. However, there are also specific and organic products to remove the smallest deposits and dirt effectively. The Limpuro brand, for example, offers an organic and gentle liquid to clean the walls of your hookah.

powder cleanser

There is also cleaning powder, more economical, but just as effective. Just dissolve it in a little water and let the mixture act directly in your shisha before rinsing thoroughly with clear water.

Colombian Senate approves cannabis legalization bill

The Colombian Senate has overwhelmingly approved a bill to legalize cannabis in Colombia, although there are still several legislative steps before it can be enacted.

The bill, which also received initial approval in the country’s House of Representatives, was approved in the Colombian Senate in the fourth round of debate on Tuesday by a vote of 56 votes in favor to 3 against.

Lawmakers have met several times in recent weeks to debate the reform proposal, which would amend the country’s Constitution to end cannabis prohibition for adults. Yesterday’s vote came about two weeks after the legalization bill was passed by the Senate First Committee.

The proposed constitutional amendment, sponsored by Deputy Juan Carlos Losada, takes into account the impacts of legalization on public health and the economy, as well as the ideological principle of individual autonomy. If passed, authorities will have six months to enact rules for the adult-use market.

The legalization bill supports “the right to free development of personality, by allowing citizens to decide on the consumption of cannabis within a regulated legal framework”. And it would mitigate “arbitrary discriminatory or unequal treatment of the population that consumes”.

The bill will limit possession and public consumption in schools and certain public spaces. It also includes public education campaigns and the promotion of addiction treatment services.

As a proposed constitutional amendment, the legislation must go through a total of eight debates, spread over two separate calendar years.

In September, the Colombian president gave a speech at a meeting of the United Nations (UN), in which he urged member countries to fundamentally change their approach to drug policy and end prohibition. .

Gustavo Petro also recently raised the prospect of legalizing cannabis in Colombia as a way to reduce the influence of the illicit market. And he indicated that this change in policy should be followed by the release of those currently imprisoned for cannabis.

He also met with the Mexican President to jointly reshape drug policies.

Agrican rhymes hemp with excellence

In the heart of Weppes, 20 minutes from Lille, Agrican has settled, a cooperative of farmers and hemp workers dedicated to creating a French center of excellence around legal cannabinoids.

From the outside of the farm, there is nothing to suggest that the company grows 3,000 hemp plants in outdoors and 10,000 feet under glass. The latter benefit from top-of-the-range installations whose light support and CO2 or heating supply reproduce the growth cycles and allow 3 to 4 harvests to be made per year. Agrican now harvests 2 tonnes of flowers per year, with cultivation carried out in an organic, responsible and transparent manner.

A multi-faceted expertise

Agrican obviously pays great attention to the cultivation of hemp plants. The good growth of the plant is found ultimately in harvest and in cannabinoid levels. Once detached from their stem, slow and controlled drying perfects the organoleptic and visual qualities of the flowers before being ripened to develop their full potential.

The result is flowers that are certainly airy for those grown outdoors, hemp remains hemp, but olfactorily interesting with natural CBD levels between 5 and 10%. We will retain from our tasting:

  • Orange Bud (outdoor), whose orange flavors form a marked olfactory reminder
  • the Chocolope (greenhouse) which navigates between sweetness and coffee
  • the Orange Sorbet (greenhouse) with its pretty flowers containing 14.9% CBD, certificate in support!
  • the Gelato (outdoor) which under its purplish looks and small buds develops 10.9% CBD and powerful smells of spices and pine

However, Agrican’s agricultural expertise is not limited to a qualitative cultivation of hemp. Everything that will not be sold in the form of flowers, to specialized shops or individuals, will be ground into biomass for the extraction carried out by their partner Green Exchange Lab. This allows them to offer French CBD extracts, in crude oilin isolate or distillate, and to go as far as the manufacture of finished products such as CBD or CBG oils, vape pen or even cosmetic products, in white label or for their distribution network.

Uruguay: cannabis with 15% THC soon in pharmacies

The executive director of the Institute for Regulation and Control of Cannabis (IRCCA), Juan Ignacio Tastás, announced during the ninth edition of ExpoCannabis Uruguay that the Uruguayan government will put on sale a third variety of cannabis with a higher level tetrahydrocannabinol (THC). This new variety could be available in the 30 authorized pharmacies in the country as of December 20.

“This third variety, in a way, will have a level of THC (tetrahydrocannabinol), or psychoactive element, less than or equal to 15%; so it would be much closer to what many customers or people were asking for. This is much closer to the THC levels you can get in the clubs. It was a very important need,” announced Juan Ignacio Tastás.

When the sale of cannabis in pharmacies was launched in Uruguay, the varieties available had only 2% THC. 4 years later, Uruguay added a 10% THC strain.

Juan Ignacio Tastás also said that they are “working on a fourth variety, which could be launched around December next year” and that they are analyzing how to guarantee universal access, which could open the door to tourism. cannabis in Uruguay. Projections estimate that allowing cannabis to tourists could bring in up to 100,000 people.

“We agree 100% on the fact that there must be a regulation that is amended legislatively so that anyone in the national territory over the age of 18 can access cannabis through legal channels and reduce the market. gray that exists today,” said Gonzalo Maciel of the Ministry of Industry, Energy and Mines.

The IRCCA board member said they are looking to “simplify access to pharmacies and discuss whether or not to buy from clubs” and that these should become ” dispensaries”. This would require changing the legal form of the clubs, which are currently non-profit associations.

As for pharmacies, which will number 40 next year throughout the country, the necessary software is being designed to allow universal access to nationals, residents and foreigners.

Other novelties announced by the IRCCA Board of Directors include the opening of a seed and cuttings registry for individuals, as well as official authorization for companies that cultivate for the State to develop their own genetics, with the aim of increasing and varying the supply.

United States: A senator introduces a bill to prepare the country for the federal legalization of cannabis

Democratic Senator John Hickenlooper officially introduced a bill last Thursday to prepare the United States for the federal legalization of cannabis.

The presentation of this text roughly coincides with the tenth anniversary of the vote of his native state, Colorado, in favor of the legalization of cannabis for adult use.

The PREPARE law for Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (Effectively Preparing Regulators for a Regulated Post-Prohibition Environment for Adults) would ask the Attorney General to create a commission to make recommendations on a cannabis regulatory system that builds on what is currently in place for the alcohol.

“Ten years after Colorado pioneered the legalization of cannabis, Americans overwhelmingly support the same at the federal level,” John Hickenlooper said in a press release. “This bipartisan, bicameral framework, based on Colorado’s Amendment 64 Task Force, will replicate our success nationally. »

The measure is identical to a bill introduced in the House of Representatives that Representatives Dave Joyce, Hakeem Jeffries and Brian Mast introduced in April.

“I am thrilled that the PREPARE Act has been introduced in the Senate, which not only makes it even more bipartisan, but bicameral, and brings it one step closer to being law,” Joyce said Thursday. “This legislation gives lawmakers on both sides of the aisle the answers they need to effectively engage in cannabis reform, regulate it safely and effectively, and address the harm caused by the failed war on cannabis. . »

“With these responses, Congress can develop a much-needed federal regulatory framework that not only respects each state’s unique needs, rights, and laws, but also ensures a responsible end to Prohibition and a safer future for our communities.” I was proud to lead the introduction of this common sense bill into the House and I thank Senator Hickenlooper for pushing it forward in the Senate. I look forward to continuing to work with him and my fellow Cannabis Caucus Co-Chairs in the House to pave the way for more comprehensive reform. »

Although Senator Hickenlooper voiced his opposition to the legalization of cannabis in Colorado in 2012 when he was governor, he has since acknowledged that many of his fears about ending Prohibition have not materialized, particularly regarding cannabis use among young people. And he is now a strong advocate for reform at the federal level.

Legal cannabis is the 6th largest cash crop in the United States

According to the new Leafly report Cannabis Harvest Report 2022 published last month, cannabis prices in the United States have plummeted despite a year of historic inflation.

Adult cannabis growers in the United States grew 554 tons more cannabis in 2022 than the previous year. Yet the value of the harvest has dropped by a billion dollars. Large-scale farming and the rise in crop technology, for example, have driven wholesale prices to historic lows in Colorado. Grams of flowers can be sold for $4 in Oregon.

How much legal weed does the US grow?

According to the second annual report Cannabis Harvest Report 2022, adult cannabis cultivators produced 2,834 tons of cannabis last year in the United States. Cannabis is thus placed behind corn, soybeans, straw, wheat and cotton as the 6th commercial crop in the United States.

According to federal usage surveys, that 2,834 tons represents only about a quarter of Americans’ annual cannabis demand.

Growers in the western United States have apparently grown too much over the past year. Meanwhile, farmers in the Midwest and East have not grown enough to meet their region’s demand. Due to federal prohibition, licensed farmers cannot sell across national borders. But the illicit market does. This dynamic hurts legal farmers in the West, while overcharging customers in the Midwest and East Coast. Residents of Illinois and Maine, for example, pay some of the highest prices for cannabis in the country. People in Colorado, Oregon and California pay some of the lowest prices.

Our results suggest Congress needs to do the will of 68% of voters and send cannabis reform bills to President Biden this year. Americans want to vote with their dollars for crafted, sustainable, long-lived cannabis, but they can’t yet.

Several dozen farmers shared their experiences with Leafly, reflecting the regional booms and busts in this evolving field. Small farms would therefore have a much harder time maintaining a healthy financial course than large companies.

“Prices this year have never been so low and honestly that is quite tragic for all the small artisanal farmers. Many people will not be able to afford to run their farm. Our community as a whole is in a bad financial situation,” explained Jason Gellman of Ridgeline Farms, yet one of the winners of the Emerald Cup 2021.

According to Gallup, about 68% of Americans are willing to end federal cannabis prohibition and move to a regulated system.

20 cannabis companies send an open letter to the European Commission

Last month, 20 cannabis companies from several countries sent an open letter to the European Commission. The translation of the letter, spotted by CannabisIndustrie, can be read below.

The letter was signed, among others, by Hanfverband, one of the German pro-legalization associations, but also by companies active in the medical cannabis market in the United Kingdom, Germany, the Czech Republic or Switzerland. No French or Dutch company signed the letter.

Letter to the European Commission

Towards a “New European Drugs Market” – Fostering Member States’ reform efforts to develop effective drug policies.

Dear Members of the European Commission,

We, representatives of the European cannabis industry and associations, take note of the fact that internationally a progressive approach to the use of cannabis for adult use has prevailed for several years. In the European Union, a growing number of Member States, including Malta, Luxembourg, the Czech Republic and the Netherlands, are beginning to reform their old prohibitive drug policies in a way that is geared towards real effectiveness, which makes it possible to put in place a new political framework for Cannabis covering all situations of use.

More recently, the government of the Federal Republic of Germany presented a document on the key points by which it intends to transform the market for cannabis for adult use, previously illegal, into a regulated framework. These reforms in no way contradict the global objectives of improving health protection. We would therefore like the European Commission to carry out a thorough and timely assessment of the capacities of European drug policy within the framework of the global drug control conventions. By sharing the German interpretation of these conventions, the Commission will enable Member States to pursue forward-looking drug policies to achieve the intentions of our global drug control conventions much more effectively than previous attempts to general prohibition.

For a long time, the cultivation, distribution and consumption of cannabis have been sought to be curtailed by prohibitive and repressive drug policies. As a result, the consumption, availability and THC content of cannabis on the unregulated illicit market has increased, while different contaminations continue to pose an unpredictable threat to the health of EU citizens. Finally, the failure of drug policies in recent decades has allowed organized crime to generate billions of dollars in revenue year after year.

Germany’s proposal aims to effectively protect youth and health and tackles the immediate weaknesses of the old prohibition paradigm, such as the expansion of the illicit market and the spread of contaminated substances. The aim of this approach is therefore in line with the objective of the 1961 and 1988 UN Conventions against trafficking in narcotic drugs and psychotropic substances and the objectives of the EU Drugs Strategy for 2021-2025.

Protecting health and strengthening health culture are at the heart of the concerns of the European Union and its Member States. We therefore see the current German approach as an important signal to move towards an urgent reform of European drug policy. In the perspective of such a “European New Drug Deal”, the balance between public health, law enforcement and the market economy is crucial to play a leading role at the international level.

In this global effort to build a new consensus, the Commission can count on the support of all stakeholders. We, the various European cannabis associations and industries, are constantly working to increase research and knowledge sharing within the epistemic community. We see ourselves as a resource for evidence-based policy making and are an ideal partner for consulting and evaluating topics. We are convinced that the European Commission will support all efforts aimed at reinforcing a paradigm shift in drug policy.

Please accept, Madam, Sir, the expression of my distinguished sentiments,

  • Tom Broockmann (Managing Director), ADREXpharma GmbH, Germany
  • Tej Virk (Managing Director and CEO), Akanda Corp, UK
  • Lars Erik Råen (CEO), Balancial AS, Denmark
  • Dr. rer. dr. David Surjo (CCDO), Canify AG, Germany
  • Stefan Jacker (COO), CanPharma GmbH, Germany
  • loana Freise (Head of Regulatory and Public Affairs), Cansativa GmbH, Germany
  • Jan Simon (CEO), CZ Pharma sro, Czech Republic, Germany
  • Dr Constantin von der Groeben (Managing Director), DEMECAN GmbH, Germany
  • Thomas Schatton (CEO), Four 20 Pharma GmbH, Germany
  • Oliver Schultz (CCO), Grünhorn, Germany
  • Šárka Betke (General Manager) High Five Group sro, Czech Republic
  • Richard Balla (CEO), IMC adjupharm GmbH, Germany
  • Michal Drdák (Commercial Manager), Lagom Pharmatech sro, Czech Republic
  • Jonathan Lubosch-Haenisch (CEO), iuvo Therapeutics GmbH, Germany
  • Georg Wurth (CEO), Deutsche Hanfverband, Germany
  • dr. med. Jaschar Kermany (CEO), Kineo Medical GmbH, Germany
  • Nick Pateras (Managing Director), Materia Global, UK
  • Antonia Menzel (Director of Public Affairs and Corporate Spokesperson) Sanity Group GmbH, Germany
  • Luc Richner (co-founder and CEO), Vigia AG, Switzerland
  • Börge Diessel (Managing Director), WEECO Pharma GmbH, Germany

Joe Biden signs cannabis research bill

US President Joe Biden has officially signed a cannabis research bill into law. He thus made history by enacting the first stand-alone federal piece of cannabis reform legislation in the United States.

The bill passed the House of Representatives in July and the Senate last month. A White House spokesperson had confirmed to Marijuana Moment that the president intended to sign him. That’s what he did on Friday.

The United States Attorney General now has 60 days to either approve the request or request additional information before the text becomes law.

Among the many provisions, the text creates a more efficient route for researchers requesting larger quantities of cannabis.

The US president remains opposed to the federal legalization of cannabis, but he has campaigned on a number of smaller reforms around cannabis, including promoting research, decriminalizing and reclassifying cannabis as a controlled substance ( Controlled Substances Act, CSA).

In October, Joe Biden also pardoned Americans en masse for federal cannabis possession offenses and ordered an administrative review of the cannabis classification. The White House recently listed these actions among the president’s “major accomplishments.”

The four co-chairs of the Congressional Cannabis Caucus — Democrats Earl Blumenauer and Barbara Lee and Republicans Dave Joyce and Brian Mast — released a joint statement after the president signed:

“For decades, the federal government has stood in the way of science and progress with a misguided and discriminatory approach to cannabis. Today marks a monumental step in fixing our federal cannabis laws,” they said. “The Medical Cannabis and Cannabidiol Research Expansion Act will facilitate the study of the impacts and potential of cannabis.”

“Research is fundamental to determining the way forward in cannabis policy. Research is essential to better understand the therapeutic benefits of cannabis that have the potential to help millions of Americans battling chronic pain, PTSD, multiple sclerosis, anxiety disorders and more. »

“We welcome the enactment of this essential and long-awaited legislation, and we know that much more needs to be done to address the continuing damage of the failed war on drugs. Our caucus will continue to work to reimagine the federal government’s approach to cannabis and enact further reforms. In the coming weeks, we are committed to passing other bipartisan, common-sense proposals like the SAFE Banking Package, the Veterans Equal Access Act, the PREPARE Act and the Safe Harbor Act. medical cannabis for veterans. »

The Swiss Federal Commission supports the legalization of cannabis

The Swiss Federal Commission on Issues Related to Addiction and the Prevention of Non-Communicable Diseases (CFANT) expressed its support for the legalization of cannabis in a press release from the Swiss Federal Council.

The Swiss parliamentary committees have already given the green light to the legalization of cannabis, a regulation which would therefore go further than the current experiments in the controlled distribution of cannabis, which are slow to start due to quality problems with cannabis and its products.

“The current cannabis policy is unsuitable,” says the CFANT, which also points to the health risks. To prevent consumers from being exposed to potentially dangerous products, “the cannabis market must be legalized and regulated”.

The simple decriminalization of consumption, the possibility of growing at home or selling through the health system “does not constitute a credible alternative to the black market. Nevertheless, underlines the commission, “nothing justifies encouraging the consumption of this medicine”, which should therefore not be promoted.

The commission is therefore positioning itself for the control of cannabis by making it accessible without advertising it.

Zurich and Basel, the first cities to experiment with the legal distribution of cannabis

Last year, the federal government announced its intention to relax the rules for medical cannabis and end cannabis prohibition. Last October, the Committee on Social Security and Health of the Council of States recommended that Switzerland legalize cannabis.

Previously, the public health commission of the National Council in Switzerland had given its approval. The government must now start drafting a bill, but it has decided to experiment first.

If the Basel and Zurich experiments have been postponed, in the first case because pesticide residues were found in the grass, the number of participating cities will lead to an experimental network that can facilitate the implementation ultimately of a federation-wide legalization of cannabis.